PT  - JOURNAL ARTICLE
AU  - Alharbi, Nader
TI  - Predicting COVID-19 Pandemic in Saudi Arabia Using Modified Singular Spectrum Analysis
AID  - 10.1101/2020.05.24.20111872
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.24.20111872
4099  - http://medrxiv.org/content/early/2020/05/26/2020.05.24.20111872.short
4100  - http://medrxiv.org/content/early/2020/05/26/2020.05.24.20111872.full
AB  - This research presents a modified Singular Spectrum Analysis (SSA) approach for the analysis of COVID-19 in Saudi Arabia. We have proposed this approach and developed it in [1–3] for separability and grouping step in SSA, which plays an important role for reconstruction and forecasting in the SSA. The modified SSA mainly enables us to identify the number of the interpretable components required for separability, signal extraction and noise reduction. The approach was examined using different number of simulated and real data with different structures and signal to noise ratio. In this study we examine its capability in analysing COVID-19 data. Then, we use Vector SSA for predicting new data points and the peak of this pandemic. The results shows that the approach can be used as a promising one in decomposing and forecasting the daily cases of COVID-19 in Saudi Arabia.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding: This research received no external funding. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Funding: This research received no external funding. Conflicts of Interest: The authors declare that there is no conflict of interestAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe daily confirmed cases of COVID-19 in Saudi Arabia [32] is used in this research. First, We have used the first 42 days data; from 02-03-2020 to 12-04-2020. https://covid19.moh.gov.sa